This inventor holds 3 USPTO granted patents. Top assignees: Ss Pharmaceutical Co., Ltd., Ssp Co. Ltd. Active years: 1995-2000.
Company Filing History:
Years Active: 1995-2000
Title: Shigeru Adegawa: Innovator in Pharmaceutical Chemistry
Introduction
Shigeru Adegawa is a notable inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinolone derivatives. With a total of 3 patents, Adegawa has established himself as a key figure in the development of new pharmaceutical compounds.
Latest Patents
Adegawa's latest patents include "Substituted quinolone derivatives and pharmaceuticals containing the same." These derivatives are represented by a specific formula where R¹ denotes a substituted or unsubstituted (hetero)aryl group, R² represents H or an alkoxycarbonyl, substituted aminocarbonyl, cyano, or similar group, and R³ and R⁴ each independently represent H or a substituted alkyl, aryl, amino, or similar group, along with their salts. These compounds exhibit excellent anti-ulcer activities, showcasing Adegawa's commitment to addressing critical health issues through innovative solutions.
Career Highlights
Throughout his career, Adegawa has worked with various companies, including Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His work in these organizations has allowed him to further his research and development efforts in pharmaceutical chemistry.
Collaborations
Adegawa has collaborated with notable coworkers such as Kazuo Yamazaki and Yoichiro Ogawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Shigeru Adegawa's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the development of effective pharmaceutical solutions.